| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cibus, Inc. (CBUS) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CBUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 894.3K | $1.22M | - | |
| CEO | 686.8K | $934.1K | - | |
| VP | 422.9K | $575.1K | - | |
| Other | 167.9K | $228.3K | - | |
| CFO | 154.3K | $209.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2019 | Sahoo Manoj | Chief Commercial Officer | Sell | 8,330 | $18.00 | $149,940.00 | -5.6% | |
| Mar 19, 2019 | Blome James | Chief Executive Officer | Sell | 2,582 | $17.32 | $44,713.01 | -1.6% | |
| Mar 14, 2019 | Ribeill Yves J | Director | Sell | 19,980 | $16.64 | $332,503.92 | -9.5% | |
| Mar 12, 2019 | Blome James | Chief Executive Officer | Sell | 2,582 | $16.58 | $42,802.33 | -1.6% | |
| Feb 25, 2019 | Voytas Daniel F | Chief Science Officer | Sale+OE | 3,977 | $16.00 | $63,632.00 | -4.1% | |
| Feb 1, 2019 | Voytas Daniel F | Chief Science Officer | Sale+OE | 8,170 | $13.00 | $106,210.00 | -4.2% | |
| Jan 4, 2019 | Dumont Philippe | Director | Sell | 1,117 | $12.00 | $13,404.00 | -6.1% | |
| Jan 2, 2019 | Sahoo Manoj | Chief Commercial Officer | Sell | 2,444 | $10.39 | $25,388.76 | -3.1% | |
| Dec 18, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $13.00 | $53,079.00 | -4.2% | |
| Nov 8, 2018 | Voytas Daniel F | Chief Science Officer | Sale+OE | 4,083 | $13.00 | $53,079.00 | -4.2% |